Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Allen

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemiaFabio Ghiotto, Franco Fais, Emilia Albesiano, et al.
Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
The Journal of Experimental Medicine|September 5, 2002
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversificationCarmela Gurrieri, Peter McGuire, Hong Zan, et al.
Frontiers in Immunology|March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient MicePiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.
British Journal of Haematology|July 25, 2015
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A Sanz, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2017
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutationRosa Catera, Yun Liu, Chao Gao, et al.
Blood|January 30, 2010
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu, Rosa Catera, Lu Zhang, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemiaFabio Ghiotto, Franco Fais, Emilia Albesiano, et al.
Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
The Journal of Experimental Medicine|September 5, 2002
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversificationCarmela Gurrieri, Peter McGuire, Hong Zan, et al.
Frontiers in Immunology|March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient MicePiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.
British Journal of Haematology|July 25, 2015
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A Sanz, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2017
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutationRosa Catera, Yun Liu, Chao Gao, et al.
Blood|January 30, 2010
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of originCharles C Chu, Rosa Catera, Lu Zhang, et al.
Pageof 9